For example, P-gp has been shown to be overexpressed in various cancers such as in 52% of acute lymphocytic leukemia (ALL) patients, and this is correlated with reduced survival and treatment resistance (Olarte Carrillo et al., 2017). Here, PGP is linked to acute lymphoblastic leukemia.